Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Antengene (6996 HK)
Watchlist
44
Analysis
Health Care
•
China
Antengene Corporation Limited operates as a specialty pharmaceutical company. The Company produces innovative drugs, selinexor, eltanexor, verdinexor, and other products. Antengene provides its services throughout China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Antengene
•
18 Nov 2020 09:39
Antengene - Insights on Pipeline and Valuation
This article analyzed the value and potential of Antengene's current pipeline, its competitors' products and also include some thoughts on valuation.
Xinyao (Criss) Wang
Follow
280 Views
Share
bullish
•
Antengene
•
10 Nov 2020 16:38
Antengene IPO: Valuation Insights
Antengene has launched an HK IPO to raise net proceeds of $318 million at the mid-point of the price range. Overall, strong cornerstones and our...
Arun George
Follow
364 Views
Share
bullish
•
Antengene
•
10 Nov 2020 00:55
Antengene: We Like the Deal
This Insight recommends participating in the IPO of Antengene considering the proposed valuation and market opportunity.
Kemp Dolliver, CFA
274 Views
Share
bullish
•
Antengene
•
09 Nov 2020 13:45
Antengene (德琪医药) IPO: Buy the Team
The deal has attracted a strong line-up of cornerstone investors. At the high end it is fairly valued but the sentiment appears to be strong again...
Ke Yan, CFA, FRM
Follow
487 Views
Share
bullish
•
Ant Group
•
08 Nov 2020 10:26
ECM Weekly (8 November 2020) - Ant, Sunac Svcs, Jinke Svcs, Antengene, Gland Pharma, Kalyan Jewel
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
Zhen Zhou, Toh
293 Views
Share
First
Previous
4
5
6
7
8
9
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x